Vittoria Biotherapeutics

BiotechnologySeedPhiladelphia, USvittoriabio.com

Latest round

Seed

Last raised

Nov 2023

Total raised

$18M

Investors

7

About Vittoria Biotherapeutics

Founded in 2021 and based in Pennsylvania, US, Vittoria Biotherapeutics, Inc. operates as a Biotechnology research company that provides technologies related to cell therapies and gene editing. The company was co-founded by Nicholas Siciliano(CEO) and Bruce Peacock. The company offers Senza5 which is a cell therapy engineering and manufacturing platform, that combines the power of genetic engineering and a proprietary five-day manufacturing process. The firm primary offering is the development of gene editing and cell therapies, with a focus on T cell engineering and CAR T cell therapies.

Who invested in Vittoria Biotherapeutics

7 investors across 2 rounds

See all investors in Vittoria Biotherapeutics

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Seed

    Nov 14, 2023

    Amount

    $9.3M

    Investors

    Locked

  2. Seed

    Jul 23, 2021

    Amount

    $8.7M

    Investors

    Locked

Questions about Vittoria Biotherapeutics

Who invested in Vittoria Biotherapeutics?

Vittoria Biotherapeutics has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Vittoria Biotherapeutics raised?

Vittoria Biotherapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Vittoria Biotherapeutics last raise money?

Vittoria Biotherapeutics's most recent round on record is a Seed, in Nov 2023.

What does Vittoria Biotherapeutics do?

Founded in 2021 and based in Pennsylvania, US, Vittoria Biotherapeutics, Inc.

Where is Vittoria Biotherapeutics headquartered?

Vittoria Biotherapeutics is headquartered in Philadelphia, US.

Which VCs invest in companies like Vittoria Biotherapeutics?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vittoria Biotherapeutics's stage. Their profiles are linked below.

Raising like Vittoria Biotherapeutics? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.